Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $870.00M.
ENTERPRISE VALUE (EV)
$870.00M
First Tracks Biotherapeutics Inc
Market Cap
$1.11B
Enterprise Value (EV)
$870.00M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| First Tracks Biotherapeutics Inc (TRAX) | $1.11B | $870.00M |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | $1.78B |
| STAAR Surgical Company (STAA)vs › | $1.10B | $991.72M |
| Replimune Group, Inc. (REPL)vs › | $1.10B | $1.03B |
| OPKO Health, Inc. (OPK)vs › | $1.09B | $1.18B |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | $992.62M |
| IRadimed Corporation (IRMD)vs › | $1.08B | $1.02B |
| Harrow Health, Inc. (HROW)vs › | $1.14B | $1.35B |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | $1.60B |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | $1.38B |
Market Cap
$1.11B
Total Debt
$0.00
Cash
$238.20M
Enterprise Value
$870.00M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
